CHRISTOPHER ELLIS: Open Payments
NPI 1578664744 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 37 payments from 8 companies in 2025. Trend: 2023 $218 · 2024 $634 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $146 |
| Biosense Webster, Inc. | 1 | $145 |
| Boston Scientific Corporation | 29 | $144 |
| Braeburn Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| ABIOMED | 1 | $101 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
Products named: REZDIFFRA, CARTO 3, BRIXADI, Ozempic, WaveWriter Alpha Prime 16, Leqembi, JOURNAVX, Intracept.
Industry payments across CA — which companies pay providers there.
